Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Microorganisms in Medicine and Therapeutics

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Nanomaterials Drive In Vivo CAR Immune Cells Engineering.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Cryogenic silicification enables nongenetic functional continuity across mammalian cell generations.

Proceedings of the National Academy of Sciences of the United States of America·2026

Same author

Harnessing Silicene-to-Silicic Acid Conversion for Organelle-Specific Silica Deposition in Tumor Therapy.

Advanced materials (Deerfield Beach, Fla.)·2026

Same author

Discordance between remnant cholesterol and LDL-C associated with the risk of new-onset cardiometabolic multimorbidity: A prospective cohort study.

Medicine·2026

Same author

Low-Value Care Following Hospital and Private Equity Acquisition in Primary Care.

Medical care research and review : MCRR·2026

Same author

Conversion-driven heterointerface reconfiguration enables fast ion migration in iron disulfide/sulfur-based positive electrodes for aqueous batteries.

Nature communications·2026

Search research articles

Related Experiment Video

Updated: Oct 7, 2025

Bioluminescent Bacterial Imaging In Vivo

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

Engineering Living Bacteria for Cancer Therapy.

Lei Rong^1,2, Qi Lei^1,3, Xian-Zheng Zhang¹

¹Key Laboratory of Biomedical Polymers of Ministry of Education & Department of Chemistry, Wuhan University, Wuhan 430072, People's Republic of China.

ACS Applied Bio Materials

|January 12, 2022

Summary

Engineered bacteria offer unique cancer treatment advantages like tumor targeting and deep penetration. Researchers are developing these living therapies for improved safety and efficacy in fighting cancer.

Keywords:

bacteria engineering bacteria modification cancer therapy living bacteria synergic therapy tumor

More Related Videos

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

Related Experiment Videos

Last Updated: Oct 7, 2025

Bioluminescent Bacterial Imaging In Vivo

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Engineering Adherent Bacteria by Creating a Single Synthetic Curli Operon

Published on: November 16, 2012

Area of Science:

Microbiology
Oncology
Biotechnology

Background:

Bacteria exhibit unique anti-cancer properties, including tumor targeting, deep tissue penetration, and programmable efficacy.
Species like *Salmonella*, *Escherichia*, *Clostridium*, and *Listeria* have shown potential in preclinical cancer models.
Some bacterial strains have progressed to clinical trials for cancer therapy.

Purpose of the Study:

To summarize strategies for engineering bacteria to combat cancer.
To provide examples of bacterial engineering approaches for enhanced safety and therapeutic index.
To highlight the potential of live bacterial therapeutics in oncology.

Main Methods:

Review of general strategies for engineering bacteria for cancer treatment.
Analysis of specific bacterial species (*Salmonella*, *Escherichia*, *Clostridium*, *Listeria*) used in cancer therapy research.
Examination of approaches to improve bacterial safety and therapeutic efficacy.

Main Results:

Demonstrated potential of engineered bacteria in restricting tumor growth and improving prognosis in mouse models.
Advancement of certain bacterial strains into clinical trials for cancer treatment.
Identification of key engineering strategies for optimizing bacterial cancer therapies.

Conclusions:

Engineered bacteria represent a promising therapeutic modality for cancer treatment.
Further development in bacterial engineering is crucial for enhancing safety and efficacy.
Live bacterial therapies hold significant potential to complement or replace conventional cancer treatments.